1. Main page
  2. United States
  3. New Hampshire
  4. Nashua
  5. Oncology in Nashua
  6. Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program
Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program image

Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program

► Operational

SPECIALTIES AVAILABLE

Location: 2300 Southwood Dr, Nashua, New Hampshire, United States — view on map

Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program offers you comprehensive inpatient and outpatient medical services across multiple specialties in Nashua, New Hampshire, United States.

Book Appointment   Contact Provider   Reviews

Quick contact: +1 603-577-4170
0
Avg rating
3+
Specialties

About the Oncology

How to book

  1. Click Book Appointment call +1 603-577-4170 .
  2. Use provider online portal: cancer.dartmouth.edu/blood-cancer.

Clinical team & doctors

No clinical team & doctors information available at the moment.

Reviews & ratings

No OnMend reviews yet.

Reviews on Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program

Verified reviews Each submission is manually reviewed for authenticity. Your privacy is protected — reviews are never shared with third parties.

Start your review of Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program.

Sign In with Google
Select your rating

Review must be at least 10 characters!

Overall rating of Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program on OnMend

Frequently Asked Questions about Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program

Where is the Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program situated at?

Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program is situated at 2300 Southwood Dr, Nashua, New Hampshire, United States.

How can I book an appointment at Dartmouth Cancer Center Nashua | Lymphoma & Leukemia Program?

You can book an appointment by clicking the "Book Appointment" button on this page or by calling the hospital directly.

Share on social media

Information last updated: November 2, 2024